Head and neck cancers constitute a major global health problem, representing a substantial proportion of cancer-related morbidity and mortality worldwide. The majority of these malignancies are head and neck squamous cell carcinomas (HNSCC), arising from the mucosal epithelium of the oral cavity, oropharynx, hypopharynx, and larynx. Major etiological factors include tobacco use, alcohol consumption, and human papillomavirus (HPV) infection, particularly in oropharyngeal cancers. Despite advances in surgical techniques, radiotherapy, and chemotherapeutic protocols, the prognosis of HNSCC remains closely linked to the status of regional lymph nodes at presentation.

Among all clinicopathological factors, the presence of cervical lymph node metastasis is the single most important determinant of prognosis in HNSCC. Nodal involvement not only signifies biologically aggressive disease but also increases the risk of locoregional recurrence and distant metastasis. It has been reported that cervical nodal metastasis reduces overall survival by approximately 50%, even in patients with relatively small primary tumors. Moreover, the presence of multiple metastatic nodes or extracapsular spread further worsens survival outcomes and necessitates more aggressive multimodal therapy.

The cervical lymphatic system provides an extensive drainage network for tumors arising in the upper aerodigestive tract, facilitating early regional dissemination. However, clinical and radiological evaluation may fail to detect occult metastasis, particularly in early-stage tumors. Therefore, identifying reliable histologic predictors of nodal spread is critical in guiding decisions regarding elective neck dissection, sentinel lymph node biopsy, and adjuvant radiotherapy or chemoradiotherapy.

Over the years, several histopathologic parameters of the primary tumor have been investigated as predictors of cervical nodal metastasis. These include:

• Tumor differentiation: Poorly differentiated tumors tend to exhibit more aggressive biological behavior and a higher likelihood of metastasis.
• Depth of invasion (DOI): Increasing DOI has been consistently associated with a greater risk of occult nodal metastasis, particularly in oral cavity cancers.
• Tumor thickness: Closely related to DOI, greater tumor thickness correlates with increased metastatic potential.
• Lymphovascular invasion (LVI): The presence of tumor emboli within vascular or lymphatic channels reflects an established pathway for tumor dissemination.
• Perineural invasion (PNI): Tumor spread along nerve sheaths is indicative of aggressive tumor biology and has been linked with higher rates of nodal and local recurrence.
• Pattern of invasion: Infiltrative and non-cohesive tumor margins are associated with increased metastatic risk compared to pushing or well-demarcated borders.
• Extracapsular spread (ECS): Although identified in metastatic lymph nodes rather than the primary tumor, ECS signifies advanced nodal disease and poor prognosis.
•  

Recent editions of the TNM staging system, particularly for oral cavity cancers, have incorporated depth of invasion as a critical component of T classification, underscoring its strong prognostic value. This modification reflects growing evidence that DOI is more predictive of nodal metastasis and survival than surface tumor size alone.

Given the significant impact of cervical lymph node metastasis on staging, therapeutic decision-making, and survival outcomes, there is a need for comprehensive evaluation of histologic predictors in patients with HNSCC. Early identification of high-risk tumors based on routine histopathological parameters may improve risk stratification and optimize individualized treatment strategies.

This study, therefore, aims to evaluate the association between specific histologic characteristics of the primary tumor and the presence of cervical nodal metastasis in patients with head and neck squamous cell carcinoma, with the goal of identifying reliable predictors that can guide clinical management.

Furthermore, understanding the correlation between histologic predictors and cervical nodal metastasis has important implications for personalized cancer management. Accurate identification of high-risk pathological features can assist clinicians in selecting patients who would benefit from elective neck dissection even in clinically node-negative (cN0) cases, thereby preventing undertreatment of occult disease. Conversely, patients lacking adverse histologic characteristics may avoid unnecessary surgical morbidity. In addition, recognizing these predictors can help refine postoperative treatment planning, particularly in determining the need for adjuvant radiotherapy or chemoradiotherapy. Therefore, a detailed evaluation of histopathological parameters not only enhances prognostic assessment but also contributes to more tailored, evidence-based therapeutic approaches in head and neck squamous cell carcinoma.

This retrospective analytical study was conducted on 200 patients diagnosed with head and neck squamous cell carcinoma (HNSCC) who underwent primary tumor excision along with therapeutic or elective neck dissection at a tertiary care hospital over a defined study period. Ethical approval was obtained from the institutional review board prior to commencement of the study, and patient confidentiality was strictly maintained throughout the research process.

Study Population

The study included patients with histopathologically confirmed HNSCC involving the oral cavity, oropharynx, hypopharynx, or larynx who underwent complete surgical resection of the primary tumor with simultaneous neck dissection.

Inclusion criteria:

• Patients aged ≥18 years
• Newly diagnosed, previously untreated HNSCC
• Availability of complete clinical records and histopathological data

Exclusion criteria:

• Patients who received neoadjuvant chemotherapy or radiotherapy
• Recurrent tumors
• Presence of distant metastasis at presentation
• Incomplete pathology reports or missing data

Data Collection

Demographic details including age and gender, as well as tumor site and clinical stage, were retrieved from hospital records. Histopathological slides and reports were reviewed. All specimens were processed using standard formalin fixation and paraffin embedding techniques, and hematoxylin and eosin (H&E) staining was used for microscopic evaluation.

Histologic Parameters Assessed

The following microscopic features of the primary tumor were evaluated:

• Tumor Grade: Categorized as well-differentiated, moderately differentiated, or poorly differentiated based on keratinization, nuclear pleomorphism, and mitotic activity.
• Depth of Invasion (DOI): Measured in millimeters from the basement membrane of the adjacent normal mucosa to the deepest point of tumor infiltration.
• Lymphovascular Invasion (LVI): Defined as the presence of tumor emboli within endothelial-lined lymphatic or vascular channels.
• Perineural Invasion (PNI): Identified when tumor cells were seen surrounding or infiltrating nerve fibers.
• Pattern of Invasion: Classified as pushing (well-circumscribed) or infiltrative (irregular, non-cohesive tumor islands at the invasive front).
• Extracapsular Spread (ECS): Evaluated in metastatic lymph nodes and defined as extension of tumor cells beyond the lymph node capsule into surrounding soft tissue.

Outcome Measures

The primary outcome variable was the presence or absence of cervical lymph node metastasis confirmed on histopathological examination of neck dissection specimens. Secondary outcomes included the number of metastatic lymph nodes and the presence of extracapsular spread.

Statistical Analysis

Data were entered into statistical software for analysis. Descriptive statistics were calculated for demographic and clinicopathological variables. Associations between histologic parameters and cervical nodal metastasis were assessed using chi-square or Fisher’s exact test for categorical variables. Multivariate logistic regression analysis was performed to identify independent predictors of nodal metastasis. A p-value of <0.05 was considered statistically significant.

This methodology allowed for a comprehensive evaluation of histologic predictors associated with cervical lymph node metastasis in a larger cohort of 200 patients with HNSCC.

Out of the 200 patients included in the study, cervical lymph node metastasis was histopathologically confirmed in 96 cases (48%), while 104 patients (52%) showed no evidence of nodal involvement.

A significant association was observed between certain histologic parameters and the presence of cervical nodal metastasis.

• Depth of Invasion (DOI): Tumors with a depth of invasion greater than 5 mm demonstrated a markedly higher rate of nodal metastasis compared to tumors with DOI ≤5 mm. Patients with DOI >5 mm were significantly more likely to have positive cervical lymph nodes (p < 0.05).
• Lymphovascular Invasion (LVI): The presence of LVI was strongly correlated with nodal involvement. A substantially higher proportion of patients with LVI-positive tumors exhibited cervical metastasis compared to those without LVI (p < 0.05).
• Perineural Invasion (PNI): PNI was also significantly associated with nodal spread. Tumors demonstrating perineural invasion had a higher incidence of metastatic lymph nodes than PNI-negative tumors (p < 0.05).
• Tumor Differentiation: Poorly differentiated tumors showed a significantly increased frequency of cervical lymph node metastasis compared to well- and moderately differentiated tumors (p < 0.05), indicating a more aggressive biological behavior.

In contrast, other parameters such as pattern of invasion showed variable association, while extracapsular spread (ECS) was observed only in cases with confirmed nodal metastasis and was associated with more advanced nodal disease.

Multivariate analysis identified DOI >5 mm, LVI, PNI, and poor tumor differentiation as independent predictors of cervical nodal metastasis.

These findings highlight the strong predictive value of specific histologic features in assessing the risk of cervical lymph node involvement in patients with HNSCC.

Table 1: Histologic Factors and Nodal Metastasis

Table 2: Tumor Grade and Nodal Metastasis

Table 3: Pattern of Invasion and Nodal Metastasis

The present study demonstrates that specific histologic parameters of the primary tumor are strongly associated with cervical lymph node metastasis in patients with head and neck squamous cell carcinoma (HNSCC). Out of 200 patients, nearly half (48%) showed nodal involvement, emphasizing the high prevalence and prognostic importance of regional metastasis in this disease. These findings reinforce the critical role of histopathological evaluation in risk stratification and treatment planning.

Among all parameters analyzed, depth of invasion (DOI) emerged as the strongest predictor of cervical nodal metastasis. Tumors with DOI greater than 5 mm were significantly more likely to have nodal involvement (72%) compared to tumors with lesser invasion. This observation aligns with the AJCC 8th edition TNM staging system, which incorporates DOI as a key factor for T classification in oral cavity cancers. A greater DOI likely reflects increased tumor aggressiveness and a higher probability of access to regional lymphatic channels, thereby facilitating early metastatic spread.

Lymphovascular invasion (LVI) and perineural invasion (PNI) were also significantly associated with nodal metastasis in this study. LVI represents the presence of tumor emboli within endothelial-lined lymphatic or blood vessels, serving as a direct route for dissemination. Similarly, PNI indicates tumor infiltration along nerve sheaths, which is often associated with locally aggressive behavior and a higher risk of regional metastasis. In our cohort, tumors exhibiting LVI and PNI demonstrated nodal positivity rates of 68% and 60%, respectively, highlighting their importance as histologic markers of metastatic potential.

Tumor differentiation was another significant predictor of nodal spread. Poorly differentiated tumors in this study showed a nodal metastasis rate of 76%, compared to 50% in moderately differentiated and 25.7% in well-differentiated tumors. Poor differentiation reflects loss of normal epithelial architecture, reduced cell adhesion, and increased invasiveness, all of which facilitate tumor dissemination to regional lymph nodes. These findings are consistent with previous studies demonstrating that tumor grade is a reliable marker of biological aggressiveness in HNSCC.

The pattern of invasion also demonstrated predictive value. Tumors with an infiltrative, non-cohesive pattern at the invasive front were more likely to metastasize to cervical nodes (62%) compared to cohesive, pushing tumors (28.6%). An infiltrative growth pattern reflects irregular tumor-host interaction, increased tumor budding, and the potential for early lymphatic invasion, further supporting its role as a high-risk feature.

Collectively, these results emphasize that routine histopathological assessment of primary tumors provides valuable prognostic information beyond clinical staging. Identifying high-risk histologic features such as DOI >5 mm, LVI, PNI, poor differentiation, and infiltrative invasion can guide surgical decision-making, including the need for elective neck dissection, and help determine which patients may benefit from adjuvant radiotherapy or chemoradiotherapy. Conversely, tumors lacking these adverse features may allow for more conservative management, minimizing treatment-related morbidity.

In conclusion, this study reinforces that a comprehensive histologic evaluation of primary HNSCC tumors is essential for predicting cervical lymph node metastasis and tailoring individualized treatment strategies. These findings support incorporation of detailed microscopic parameters into routine pathology reporting to improve prognostication and optimize patient outcomes.

This study highlights the critical role of histologic parameters in predicting cervical lymph node metastasis in patients with head and neck squamous cell carcinoma (HNSCC). Among the factors analyzed, depth of invasion (DOI), lymphovascular invasion (LVI), perineural invasion (PNI), tumor differentiation, and pattern of invasion were identified as significant predictors of regional nodal spread. Tumors exhibiting greater DOI, presence of LVI or PNI, poor differentiation, or an infiltrative growth pattern demonstrated markedly higher rates of cervical metastasis, reflecting more aggressive tumor biology and a higher risk of locoregional progression.

These findings underscore the importance of comprehensive histopathological evaluation in the management of HNSCC. Incorporating these histologic predictors into routine pathology reporting can facilitate accurate risk stratification, allowing clinicians to tailor treatment strategies appropriately. Specifically, patients with high-risk features may benefit from elective neck dissection and adjuvant therapy, even in the absence of clinically apparent nodal disease, whereas patients lacking such adverse features may be considered for more conservative management.

In summary, histologic assessment provides essential prognostic information that complements clinical staging and imaging, guiding individualized treatment planning to improve survival outcomes and optimize patient care in head and neck cancers.

1. Woolgar JA. Histological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006;42(3):229–239. DOI:1016/j.oraloncology.2005.07.014.
2. Almangush A, Bello IO, Keski-Säntti H, et al. Depth of invasion as a predictor of nodal metastasis in oral tongue carcinoma. Oral Oncol. 2014;50(6):611–616 DOI:1016/j.oraloncology.2014.03.001.
3. Pentenero M, Gandolfo S, Carrozzo M. Importance of tumor thickness in oral cancer. Oral Oncol. 2005;41(6):557–564.
4. Brandwein-Gensler M, Smith RV. Prognostic factors in head and neck cancer. Semin Diagn Pathol. 2004;21(1):15–28.
5. Close LG, Brown PM, Vuitch F, Reisch J, Schaefer SD. Microvascular invasion and nodal metastasis. Arch Otolaryngol Head Neck Surg. 1989;115(11):1309–1313 DOI:1001/archotol.1989.01860350021006.

2. Lydiatt WM, Patel SG, O’Sullivan B, et al. AJCC cancer staging manual (8th edition). CA Cancer J Clin. 2017;67(2):122–137. DOI: 3322/caac.21388.
3. Woolgar JA, Triantafyllou A. Perineural invasion and prognosis. Oral Oncol. 2009;45(6):523–530. DOI:1016/j.oraloncology.2008.07.005.
4. Myers JN, Greenberg JS, Mo V, Roberts D. Extracapsular spread and prognosis. Cancer. 2001;92(12):3030–3036.
5. Larsen SR, Johansen J, Sørensen JA, Krogdahl A. The prognostic significance of histological features. J Laryngol Otol. 2009;123(9):1040–1045.
6. Huang SH, Hwang D, Lockwood G, et al. Predictive value of tumor depth. Head Neck. 2009;31(9):1131–1137. DOI:1002/hed.21070.
7. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 8th ed. Springer; 2017.
8. Kurokawa H, Yamashita Y, Takeda S, et al. Risk factors for cervical lymph node metastasis. Oral Surg Oral Med Oral Pathol. 1998;85(2):154–158.
9. Bryne M, Boysen M, Alfsen CG, et al. Tumor budding and nodal metastasis. J Pathol. 1992;168(2):125–129. DOI:1002/path.1711680203.
10. Rogers SN, Brown JS, Woolgar JA, et al. The prognostic value of perineural invasion. Head Neck. 2003;25(7):541–549. DOI:1002/hed.10255.
11. Mendenhall WM, Mancuso AA, Parsons JT, et al. Head and neck cancer prognostic factors. Cancer. 1992;69(4):973–979.